Skip to content Skip to navigation menu 21 January 2009 A deal
has been agreed between two leading medical technology
development companies to advance new lens-free imaging equipment
co-developed by scientists at the School of Medicine and the
Gray Cancer Institute Oxford. With the potential to speed-up
disease diagnosis and drug screening, the technology transfer
agreement will see Cancer Research Technology Limited, the
oncology-focused development and commercialisation company, and
the technology development specialists The Technology
Partnership plc take forward CyMap. CyMap is one of the
inventions emerging from the Optical Biochips Consortium led by
the University’s Professor of Cancer Biology, Professor Paul
Smith. Professor Smith was in overall charge of the £2.3 million
biochip project carried out by the Consortium and funded by
Research Councils UK. CyMap is a lensless imaging chip able to
detect a range of particle types in a solution and holds the
potential to be used in highly cost-effective medi